Skip to main content

Magellan Health Announces Third Quarter 2019 Earnings Conference Call

Magellan Health, Inc. (NASDAQ: MGLN) today announced that it will report its earnings for the third quarter ended on September 30, 2019 at approximately 6:30 a.m. Eastern on Friday, November 1, 2019. At 8:00 a.m. Eastern on the same day, Magellan's management will host a conference call and webcast to discuss earnings and other information.

The call-in numbers and passcode for the conference call are as follows:

Live Call
1-800-857-1812
Passcode: 3rd Quarter 2019 Earnings

Replay
1-800-570-8791 (Domestic)
1-402-344-6824 (International)

To participate in the conference call, dial in approximately 10 minutes before the start of the call. The conference call will also be available live via webcast at Magellan's investor relations page at IR.MagellanHealth.com.

A telephonic replay will be available shortly after the conclusion of the call through December 1, 2019. A replay of the webcast will also be available at the site listed above for 30 days, beginning approximately two hours after its conclusion.

About Magellan Health: Magellan Health, Inc., a Fortune 500 company, is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit MagellanHealth.com.

(MGLN-GEN)

Contacts:

Media: Lilly Ackley, ackleyl@magellanhealth.com, (860) 507-1923
Investor: Joe Bogdan, jbogdan@magellanhealth.com, (860) 507-1910

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.